TSX:TMD - Toronto Stock Exchange - CA88830X8199 - Common Stock - Currency: CAD
TSX:TMD (11/22/2024, 7:00:00 PM)
0.8
-0.04 (-4.76%)
The current stock price of TMD.CA is 0.8 CAD. In the past month the price decreased by -29.2%. In the past year, price increased by 841.18%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 178.80M | ||
MIR.CA | MEDMIRA INC | N/A | 64.46M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 47.08M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 36.47M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 28.87M | ||
ASG.CA | AURORA SPINE CORP | N/A | 23.17M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 21.20M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 18.59M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 17.86M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 6.82M | ||
VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 659.10K | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 300.85K |
Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
TITAN MEDICAL INC
76 Berkeley Street
TORONTO ONTARIO M5H 3B7 CA
CEO: David J. McNally
Employees: 4
Phone: 14165487522
The current stock price of TMD.CA is 0.8 CAD. The price decreased by -4.76% in the last trading session.
The exchange symbol of TITAN MEDICAL INC is TMD and it is listed on the Toronto Stock Exchange exchange.
TMD.CA stock is listed on the Toronto Stock Exchange exchange.
TITAN MEDICAL INC (TMD.CA) has a market capitalization of 35.40M CAD. This makes TMD.CA a Nano Cap stock.
TITAN MEDICAL INC (TMD.CA) currently has 4 employees.
TITAN MEDICAL INC (TMD.CA) has a resistance level at 1.2. Check the full technical report for a detailed analysis of TMD.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TMD.CA does not pay a dividend.
TITAN MEDICAL INC (TMD.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
ChartMill assigns a technical rating of 7 / 10 to TMD.CA. When comparing the yearly performance of all stocks, TMD.CA is one of the better performing stocks in the market, outperforming 99.94% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA. The financial health of TMD.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months TMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 65.9% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -111.81% | ||
ROE | -184.94% | ||
Debt/Equity | 0.22 |
ChartMill assigns a Buy % Consensus number of 80% to TMD.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.